Lymphoma Trial, Recruiting (NCT05333367)

Lymphoma Trial, Recruiting NCT05333367 Sponsor: Centre Hospitalier Universitaire de Besancon Condition: Lymphoma

Printed from Voxsanity (voxsanity.com.au) — NCT05333367 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lymphoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are adults (18 years of age or older)
People who have been receiving a treatment called extracorporeal photopheresis (ECP) for at least 1 month, used for one of the following conditions: a complication called graft-versus-host disease (GVHD) after a bone marrow or stem cell transplant, rejection of a transplanted solid organ (such as a heart, lung, or kidney), or a type of skin cancer called cutaneous T-cell lymphoma

Who may not be able to join:

People who do not have full legal capacity to make decisions for themselves
People whom the trial doctor believes are unlikely to be able to follow the study procedures as required
People who do not have social security coverage (confirm with trial site regarding what this means in your country)
People who are pregnant
People who are currently in an exclusion period from another clinical trial, or who are listed in a national registry of clinical trial participants as being unavailable to join a new study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33381218875

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05333367

Sponsor: Centre Hospitalier Universitaire de Besancon

Phase: Not Applicable

Status: Recruiting

Condition: Lymphoma

Trial contact: +33381218875

More information: https://clinicaltrials.gov/study/NCT05333367

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are adults (18 years of age or older)
People who have been receiving a treatment called extracorporeal photopheresis (ECP) for at least 1 month, used for one of the following conditions: a complication called graft-versus-host disease (GVHD) after a bone marrow or stem cell transplant, rejection of a transplanted solid organ (such as a heart, lung, or kidney), or a type of skin cancer called cutaneous T-cell lymphoma

Who may not be able to join:

People who do not have full legal capacity to make decisions for themselves
People whom the trial doctor believes are unlikely to be able to follow the study procedures as required
People who do not have social security coverage (confirm with trial site regarding what this means in your country)
People who are pregnant
People who are currently in an exclusion period from another clinical trial, or who are listed in a national registry of clinical trial participants as being unavailable to join a new study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Besancon

Registry

ClinicalTrials.gov

Start date

15 April 2022

Est. completion

1 July 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Type of cell death induced by 8-MOP sensitization and UVA irradiation; Type of cell death induced by 8-MOP sensitization and UVA irradiation; Type of cell death induced by 8-MOP sensitization and UVA irradiation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov